🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now JAMA Oncology - commentary on the ACHIEVE study in #EGFR NSCLC and on dose selection for targeted therapy in general. Proud to have worked on this under the direction of Dr. Jennifer A. Marks, MD. jamanetwork.com/journals/jamao…

Losing my Father to Lung Cancer was tough then to find out my Mother has Lung Cancer hit me hard, the turning point was when I was diagnosed, I was done with this evil disease. Lung Cancer gave me a voice! #10downingstreet #lungcancerscreening #screeningsaveslives #LSC

One lung cancer mutation that has new targeted therapies available in recent years is the EGFR Exon 20 insertion mutation. Learn more about what it is and how it is treated on our blog: on.lung.org/3TmF6vd

Advances in the treatment of brain metastases in EGFR-mutant non-small cell lung cancer Lung Cancer Journal lungcancerjournal.info/article/S0169-…

The terrifying rise of alternative cancer coaches - and the nonsense they told me to do to cure my cancer In today’s MailonSunday Health Read it here pressreader.com/uk/the-mail-on… Read more in my book ‘The Cancer Roadmap’ uk.bookshop.org/p/books/the-ca… HarperCollinsUK Gabriel Shemirani

How should clinicians approach resectable EGFR-mutant #NSCLC? On the latest #LungCancerConsidered episode, Stephen V Liu, MD moderates a case discussion with Collin Blakely MD, PhD and Chunxia Su(Susu), covering evolving strategies and clinical decision-making. 🎧 bit.ly/VTBregfrnsclc

At UK Prime Minister yesterday with my fabulous Lung Cancer CNS Sharon Gill and was great to have the opportunity to highlight that all you need is lungs to get lung cancer EGFR Positive Lung Cancer UK Never smokers get it too. So important to keep raising awareness to this.

Last week, 4 #lungcancer advocates from LuCE member organisations took part in WECAN Academy 2025 - a European training programme for cancer advocacy. From HTA to clinical trials to the lived reality of pushing for better access, it was a full-on few days of learning,

Advances in the treatment of brain metastases in EGFR-mutant NSCLC lungcancerjournal.info/article/S0169-… ✅ This paper comprehensively explores the pathological mechanisms of BM in EGFR-mutant NSCLC, covering key aspects such as tumor cell invasion, EMT, exosome secretion, and BBB disruption.

J-REGISTER: real-world study of Japanese pts with EGFR mutation-positive NSCLC treated with first-line afatinib ✅Median overall time on treatment was highest in pts who received sequential afatinib and osimertinib (32.8 mon). Median OS was 41.2 mon. tandfonline.com/doi/full/10.10…

Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study Adding chemo to osimertinib may benefit patients w/ EGFR + TP53 (L858R) more than those w/ Exon 19 del nature.com/articles/s4159…

🔥🚨OncoAlert Hot Off The Press U.S. FDA approves: ✅ #Sunvozertinib For: 🔘Advanced non-small cell #LungCancer (#NSCLC) with: 🎯#EGFR #Exon20 insertion mutations, and disease progression on or after chemotherapy. ⭐️#ORR 46% and #DOR 11.1 months 👇🏻 fda.gov/drugs/resource…

🆕 Nature study on #lungcancer in never-smokers challenges long-held assumptions. ✅ Air pollution linked to key mutations ✅ EGFR most common in East Asia ❌ Secondhand smoke not a major factor - minimal genomic impact 68% of our EGFR+ UK members (2024 data) are never-smokers

In Aug ’21, I was unwell, had 2 biopsies & waited weeks for answers. A liquid biopsy trial gave me an ALK+ #lungcancer diagnosis in 10 days. Now NHS England is rolling this out! 🎙️ Alastair Greystoke & I spoke w Roy Castle Lung Cancer Foundation on this & more: 👉 roycastle.org/our-support/po… #LCSM

What’s helped you cope with #lungcancer? Our mental health + lung cancer survey is already our biggest yet but there’s still time to go further. 2 days left. 10–15 mins. 19 languages. If we don’t speak up about the emotional toll, we risk being ignored. Take part. Share it.

Case Report: Peritoneal and small bowel metastasis from lung adenocarcinoma with EGFR L858R mutation frontiersin.org/journals/oncol…

🚨INTERVIEW: Tomorrow new NHS England chair Penny Dash will publish her review into patient safety. She sat down with The Sunday Times to explain her views on the NHS and what needs to change: READ: thetimes.com/article/f90d6b…

At OncLive Dr. Sandip Patel, Dr. Zofia Piotrowska, and Dr. Joel Neal break down how the biology of metastatic spread in EGFR-mutated non–small cell lung cancer. #lungcancer buff.ly/WXgDLPs